CPRX
XNASCATALYST PHARMACEUTICALS INC
2 news · 90d
0 news · vs previous 7d (—)
Acceleration —
Sentiment scores computed by AI · Not investment advice.
Track $CPRX sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 2
How did the price react? →- GlobalNewswire5/7/2026, 7:25:00 AMAngelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
Angelini Pharma has entered into a definitive agreement to acquire Catalyst Pharmaceuticals for $4.1 billion USD (€3.5 billion), marking Angelini's entry into the U.S. market. The deal consolidates Angelini's position in brain health and rare disease therapeutics. No financing or closing timeline details were provided in the announcement.
Sentiment 0.85Relevance 100% - SeekingAlpha5/7/2026, 6:50:27 AMAngelini Pharma to buy Catalyst Pharmaceuticals for $4.1B
Angelini Pharma has agreed to acquire Catalyst Pharmaceuticals in a deal valued at $4.1 billion. The transaction represents a confirmed M&A event for Catalyst Pharmaceuticals. No additional deal terms or closing conditions were provided in the article.
Sentiment 0.95Relevance 100%